FDA Issues Recall Alert for Some Drugs Containing Valsartan
The FDA recently issued multiple safety alerts announcing voluntary recalls of drug products containing the active ingredient valsartan from a specific supply source. (Source: AAFP News)
Source: AAFP News - July 25, 2018 Category: Primary Care Source Type: news
Affected by the Valsartan Heart Drug Recall? Here's What to Do
Title: Affected by the Valsartan Heart Drug Recall? Here's What to DoCategory: Health NewsCreated: 7/19/2018 12:00:00 AMLast Editorial Review: 7/20/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 20, 2018 Category: Cardiology Source Type: news
India launches probe as Chinese company recalls BP drug
Valsartan is used to treat patients with high blood pressure in order to reduce complications such as heart attack and stroke. Both the importer and the manufacturer, Zhejiang Huahai Pharmaceuticals, will be issued notice soon. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2018 Category: Pharmaceuticals Source Type: news
FDA Recalls Drugs Containing Active Ingredient Valsartan
THURSDAY, July 19, 2018 -- Several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure, are being recalled due to an impurity, N-nitrosodimethylamine, that has been found in the recalled... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 19, 2018 Category: Pharmaceuticals Source Type: news
Affected by the Valsartan Heart Drug Recall? Here's What to Do
THURSDAY, July 19, 2018 -- After the U.S. Food and Drug Administration announced last week that certain brands of blood pressure medicines contained a carcinogen and were being recalled, many patients may wonder what ' s next for their cardiovascular... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 19, 2018 Category: General Medicine Source Type: news
Chinese pharma firm recalls heart drug in U.S. after possible impurity
The Chinese bulk manufacturer of the common blood and heart drug valsartan said it was recalling the product from consumers in the United States and would halt supplies to the country, after an impurity linked to cancer had been detected. (Source: Reuters: Health)
Source: Reuters: Health - July 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Valsartan drug recall: 4 things patients should know
Several common drugs that contain valsartan, used to treat high blood pressure and heart failure, were recalled in the United States on Friday due to an "impurity" in the drug that poses a potential cancer risk. (Source: CNN.com - Health)
Source: CNN.com - Health - July 19, 2018 Category: Consumer Health News Source Type: news
US regulators recall blood pressure drug over cancer fears
The UK recalled valsartan two weeks ago, America has now followed suit. The drug has been widely prescribed globally for 15 years. But new evidence suggests that batches have been contaminated. (Source: the Mail online | Health)
Source: the Mail online | Health - July 18, 2018 Category: Consumer Health News Source Type: news
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets
Teva Pharmaceuticals USA today confirmed a voluntary recall to the consumer / user level of 29 lots of single and 51 lots of combination valsartan medicines distributed under the Actavis label in the U.S. due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceutical. The impurity detected in the API is N- nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International ...
Source: Food and Drug Administration - July 17, 2018 Category: Food Science Source Type: news
3 Companies Recall Blood Pressure Medications Over Cancer Fears
Some drugs used to control high blood pressure and prevent heart failure were voluntarily recalled this past week due to an impurity that could possibly lead to cancer, the U.S. Food and Drug Administration said.
These products — with the active ingredient valsartan, a generic drug used to treat high blood pressure — may contain N-nitrosodimethylamine (NDMA), a possible human carcinogen. The FDA asked three companies, Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals Industries Ltd., to recall their valsartan products. Solco and Teva were also asked to recall their drugs containing valsartan/hydr...
Source: TIME: Health - July 17, 2018 Category: Consumer Health News Authors: Jennifer Calfas Tags: Uncategorized medicine onetime Source Type: news
Blood Pressure Medicine Is Recalled
The F.D.A. announced that batches of a widely used generic drug, valsartan, made in China, might be tainted with a probable cancer-causing ingredient. (Source: NYT Health)
Source: NYT Health - July 16, 2018 Category: Consumer Health News Authors: SHEILA KAPLAN Tags: Drugs (Pharmaceuticals) Recalls and Bans of Products Food and Drug Administration China Blood Pressure valsartan Source Type: news
Major Pharmaceuticals Issues Voluntary Nationwide Recall of Valsartan Due to The Potential Presence of a Probable Carcinogen (NDMA)
As a precautionary measure, the distribution firm, Major Pharmaceuticals, is issuing a nationwide voluntary recall of all lots within expiry of Valsartan which were supplied by Teva Pharmaceuticals and labeled as Major Pharmaceuticals. (Source: Food and Drug Administration)
Source: Food and Drug Administration - July 16, 2018 Category: Food Science Source Type: news
Valsartan Recall; Wearable Salt Tracker; Killer Plastic Surgery Clots
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 16, 2018 Category: Cardiology Source Type: news
FDA Recalls Some Valsartan Drugs Due to Impurity
The FDA is investigating how much NDMA is in the recalled products and is trying to find out the possible effects on patients who have been taking them. (Source: WebMD Health)
Source: WebMD Health - July 16, 2018 Category: Consumer Health News Source Type: news
FDA recalls heart failure, blood pressure drugs due to cancerous contaminant
The FDA announced last week a voluntary recall of several high blood pressure and heart failure medications containing valsartan due to a cancerous impurity.
Some valsartan drugs were found to contain N-nitrosodimethylamine (NDMA), a compound that is classified as a probable human carcinogen.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA recalls heart failure, blood pressure drugs due to cancerous contaminant appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 16, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Food & Drug Administration (FDA) Pharmaceuticals Recalls Regulatory/Compliance Wall Street Beat Teva Pharmaceuticals Source Type: news
